References
- Seppälä M, Koistinen H, Koistinen R, Chiu PC, Yeung WS. Glycosylation related actions of glycodelin: Gamete, cumulus cell, immune cell and clinical associations. Hum Reprod Update 2007;13:275–287.
- Brosens I, Pijnenborg R, Vercruysse L, Romero R.. “The great obstetrical Syndromes” are associated with disorder of deep placentation. Am J Obstet Gynecol 2011;204:193–201.
- Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA, Parthasarathy S. Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA 2001;98:9265–9270.
- Kämäräinen M, Seppälä M, Virtanen I, Andersson LC. Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 1997;77:565–573.
- Hautala LC, Koistinen R, Seppälä M, Bützow R, Stenman UH, Laakkonen P, Koistinen H. Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer 2008;123:2279–2284.
- Pala A, Padula F, Barteri M, Benagiano M, Gaudiano MC, Moro M, Benagiano G. Rapid purification and properties of human glycodelin (endometrial alpha2-globulin). J Chromatogr B Biomed Sci Appl 1997;704:25–34.
- Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 2006;27:939–958.
- Bulla R, Villa A, Bossi F, Cassetti A, Radillo O, Spessotto P, De Seta F, et al. VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp Cell Res 2005;303:101–113.